Literature DB >> 24297311

Evidences for the existence of intermolecular disulfide-bonded oligomers in the H3 hemagglutinins expressed in insect cells.

Shun Xu1, Jianqiang Zhou, Qiliang Liu, Kang Liu, Chunyi Xue, Xiaoming Li, Jing Zheng, Dongyu Luo, Yongchang Cao.   

Abstract

The hemagglutinin (HA) protein as the predominant antigen, executes receptor binding and membrane fusion, which critically influence the virological characteristics of influenza viruses. The literature contained scattered data showing reduction-sensitive HA oligomers when HA proteins were analyzed under non-reducing conditions. However, whether the reduction-sensitive HA oligomers are inter-monomer disulfide-bonded has not been studied. Here, we showed: (1) the detection of β-mercaptoethanol-sensitive H3 HA oligomers was not affected by the treatment of cells with iodoacetamide prior to cell solubilization; (2) H3 HA oligomers were present on cell surfaces; (3) H3 HA oligomers had higher density than monomers; and (4) mutation of all the five C-terminal cysteines completely abolished the formation of H3 HA oligomers. Furthermore, mutant HAs with mutations of TM cysteines, CT cysteines or all five cysteines had decreased thermal stability but increased fusion activity in comparison with wildtype HA. In conclusion, this study has presented enough evidence for the existence of inter-monomer S-S H3 HA oligomers formed by five C-terminal cysteines, and suggested that all five C-terminal cysteines exerted opposite effects on HA thermal stability and fusion activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24297311     DOI: 10.1007/s11262-013-1021-0

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  23 in total

1.  Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion.

Authors:  G B Melikyan; S Lin; M G Roth; F S Cohen
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

2.  Structural characterization of an early fusion intermediate of influenza virus hemagglutinin.

Authors:  Rui Xu; Ian A Wilson
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

3.  Fusion activity of transmembrane and cytoplasmic domain chimeras of the influenza virus glycoprotein hemagglutinin.

Authors:  B Schroth-Diez; E Ponimaskin; H Reverey; M F Schmidt; A Herrmann
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

4.  Insertion of a coiled-coil peptide from influenza virus hemagglutinin into membranes.

Authors:  Y G Yu; D S King; Y K Shin
Journal:  Science       Date:  1994-10-14       Impact factor: 47.728

5.  Disulfide bonding in influenza virus proteins as revealed by polyacrylamide gel electrophoresis.

Authors:  L M Selimova; V M Zaides; V M Zhdanov
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

Review 6.  Emergence and pandemic potential of swine-origin H1N1 influenza virus.

Authors:  Gabriele Neumann; Takeshi Noda; Yoshihiro Kawaoka
Journal:  Nature       Date:  2009-06-18       Impact factor: 49.962

7.  Amino acid residues in the fusion peptide pocket regulate the pH of activation of the H5N1 influenza virus hemagglutinin protein.

Authors:  Mark L Reed; Hui-Ling Yen; Rebecca M DuBois; Olga A Bridges; Rachelle Salomon; Robert G Webster; Charles J Russell
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

Review 8.  Influenza hemagglutinin and neuraminidase membrane glycoproteins.

Authors:  Steven J Gamblin; John J Skehel
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

9.  A rapid Flp-In system for expression of secreted H5N1 influenza hemagglutinin vaccine immunogen in mammalian cells.

Authors:  Hanxin Lu; Surender Khurana; Nitin Verma; Jody Manischewitz; Lisa King; John H Beigel; Hana Golding
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

10.  The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition.

Authors:  R T Armstrong; A S Kushnir; J M White
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more
  5 in total

1.  Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss.

Authors:  Kathleen M Holtz; Pamela S Robinson; Erin E Matthews; Yoshifumi Hashimoto; Clifton E McPherson; Nikolai Khramtsov; Michael J Reifler; Jamal Meghrous; David G Rhodes; Manon M Cox; Indresh K Srivastava
Journal:  BMC Biotechnol       Date:  2014-12-24       Impact factor: 2.563

2.  Recombinant influenza H9N2 virus with a substitution of H3 hemagglutinin transmembrane domain showed enhanced immunogenicity in mice and chicken.

Authors:  Yun Zhang; Ying Wei; Kang Liu; Mengjiao Huang; Ran Li; Yang Wang; Qiliang Liu; Jing Zheng; Chunyi Xue; Yongchang Cao
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

3.  Disulfide isomerase ERp57 improves the stability and immunogenicity of H3N2 influenza virus hemagglutinin.

Authors:  Jialing Wu; Yang Wang; Ying Wei; Zhichao Xu; Xin Tan; Zhihui Wu; Jing Zheng; George Dacai Liu; Yongchang Cao; Chunyi Xue
Journal:  Virol J       Date:  2020-04-21       Impact factor: 4.099

Review 4.  Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus.

Authors:  Yun Zhang; Cong Xu; Hao Zhang; George Dacai Liu; Chunyi Xue; Yongchang Cao
Journal:  Viruses       Date:  2019-04-30       Impact factor: 5.048

5.  H7 virus-like particles assembled by hemagglutinin containing H3N2 transmembrane domain and M1 induce broad homologous and heterologous protection in mice.

Authors:  Jianru Qin; Yun Zhang; Xiaoting Shen; Lang Gong; Ouyang Peng; Yuan Liu; Chunyi Xue; Yongchang Cao
Journal:  Vaccine       Date:  2018-07-07       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.